Virgin Galactic Holdings, Inc - Quarter Report: 2022 March (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2022
OR
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File No. 001-38202
Virgin Galactic Holdings, Inc. | ||
(Exact name of registrant as specified in its charter) |
Delaware | 85-3608069 | |||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
1700 Flight Way Tustin, California | 92782 | |||||||
(Address of Principal Executive Offices) | (Zip Code) |
(575) 424-2100 | ||
(Registrant’s telephone number, including area code) |
N/A | ||
(Former name, former address and former fiscal year, if changed since last report) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Common stock, $0.0001 par value per share | SPCE | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☒ | Accelerated filer | ☐ | ||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||||
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐ No ☒
As of May 2, 2022, there were 258,589,981 shares of the Company’s common stock, par value $0.0001, issued and outstanding.
VIRGIN GALACTIC HOLDINGS, INC.
TABLE OF CONTENTS
Page | ||||||||
1
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements (including within the meaning of the Private Securities Litigation Reform Act of 1995) concerning us and other matters. These statements may discuss goals, intentions and expectations as to future plans, trends, events, results of operations or financial condition, or otherwise, based on current beliefs of management, as well as assumptions made by, and information currently available to management. Forward-looking statements may be accompanied by words such as “achieve,” “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “future,” “grow,” “increase,” “intend,” “may,” “opportunity,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strategy,” “target,” “will,” “would,” or similar words, phrases, or expressions. These forward-looking statements are subject to various risks and uncertainties, many of which are outside our control. Therefore, you should not place undue reliance on such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, the following:
•any delay in completing the flight test program and final development of our spaceflight fleet, which is comprised of our SpaceShipTwo spaceships, VSS Unity and VSS Imagine, and our mothership carrier aircraft, VMS Eve;
•our ability to conduct test flights;
•our ability to operate our spaceflight system after commercial launch;
•the safety of our spaceflight systems;
•the development of the markets for commercial human spaceflight and commercial research and development payloads;
•our ability to effectively market and sell human spaceflights;
•our ability to convert our backlog or inbound inquiries into revenue;
•our anticipated full passenger capacity;
•our ability to achieve or maintain profitability;
•delay in development or the manufacture of spaceflight systems;
•our ability to supply our technology to additional market opportunities;
•our expected capital requirements and the availability of additional financing;
•our ability to attract or retain highly qualified personnel;
•the impact of the COVID-19 pandemic on us, our operations, our future financial or operational results, and our access to additional financing;
•extensive and evolving government regulation that impact the way we operate;
•risks associated with international expansion;
•our ability to maintain effective internal control over financial reporting and disclosure and procedures; and
•our ability to continue to use, maintain, enforce, protect and defend our owned and licensed intellectual property, including the Virgin brand.
Additional factors that may cause actual results to differ materially from current expectations include, among other things, those set forth in Part I, Item 1.“Business,” Part I, Item 1A. “Risk Factors,” and Part I, Item 2. “Management's Discussion and Analysis of Financial Condition and Results of Operations" of our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the "Annual Report on Form 10-K") and in Part I, Item 2. “Management's Discussion and Analysis of Financial Condition and Results of Operations" in this Quarterly Report on Form 10-Q. Although we believe that the expectations reflected in the forward-looking statements are reasonable, our information may be incomplete or limited, and
2
we cannot guarantee future results. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.
Each of the terms the “Company,” “Virgin Galactic,” “we,” “our,” “us” and similar terms used herein refer collectively to Virgin Galactic Holdings, Inc., a Delaware corporation, and its consolidated subsidiaries, unless otherwise stated.
3
PART I. FINANCIAL INFORMATION
VIRGIN GALACTIC HOLDINGS, INC.
Condensed Consolidated Balance Sheets
(In thousands, except share data)
March 31, 2022 | December 31, 2021 | |||||||||||||
(Unaudited) | ||||||||||||||
Assets | ||||||||||||||
Current assets | ||||||||||||||
Cash and cash equivalents | $ | 601,464 | $ | 524,481 | ||||||||||
Restricted cash | 35,361 | 25,549 | ||||||||||||
Marketable securities, short-term | 265,859 | 79,418 | ||||||||||||
Inventories | 29,467 | 29,668 | ||||||||||||
Prepaid expenses and other current assets | 17,433 | 19,476 | ||||||||||||
Total current assets | 949,584 | 678,592 | ||||||||||||
Marketable securities, long-term | 314,140 | 301,463 | ||||||||||||
Property, plant, and equipment, net | 47,476 | 47,498 | ||||||||||||
Other non-current assets | 40,944 | 41,281 | ||||||||||||
Total assets | $ | 1,352,144 | $ | 1,068,834 | ||||||||||
Liabilities and Stockholders' Equity | ||||||||||||||
Current liabilities: | ||||||||||||||
Accounts payable | $ | 9,711 | $ | 9,237 | ||||||||||
Accrued liabilities | 30,552 | 28,787 | ||||||||||||
Customer deposits | 100,091 | 90,863 | ||||||||||||
Other current liabilities | 2,529 | 2,636 | ||||||||||||
Total current liabilities | 142,883 | 131,523 | ||||||||||||
Non-current liabilities: | ||||||||||||||
Convertible senior notes, net | 414,155 | — | ||||||||||||
Other long-term liabilities | 43,009 | 43,047 | ||||||||||||
Total liabilities | 600,047 | 174,570 | ||||||||||||
Stockholders' Equity | ||||||||||||||
Preferred stock, $0.0001 par value; 10,000,000 authorized; none issued and outstanding | — | — | ||||||||||||
Common stock, $0.0001 par value; 700,000,000 shares authorized; 258,473,888 and 258,166,417 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively | 26 | 26 | ||||||||||||
Additional paid-in capital | 1,976,445 | 2,019,750 | ||||||||||||
Accumulated deficit | (1,216,700) | (1,123,643) | ||||||||||||
Accumulated other comprehensive income | (7,674) | (1,869) | ||||||||||||
Total stockholders' equity | 752,097 | 894,264 | ||||||||||||
Total liabilities and stockholders' equity | $ | 1,352,144 | $ | 1,068,834 |
4
VIRGIN GALACTIC HOLDINGS, INC.
Condensed Consolidated Statements of Operations and Comprehensive Loss
(In thousands except for per share data)
(Unaudited)
Three Months Ended March 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
Revenue | $ | 319 | $ | — | ||||||||||
Operating expenses: | ||||||||||||||
Customer experience | 25 | — | ||||||||||||
Selling, general, and administrative | 37,007 | 43,319 | ||||||||||||
Research and development | 51,827 | 35,089 | ||||||||||||
Depreciation and amortization | 2,852 | 2,869 | ||||||||||||
Total operating expenses | 91,711 | 81,277 | ||||||||||||
Operating loss | (91,392) | (81,277) | ||||||||||||
Interest income | 818 | 325 | ||||||||||||
Interest expense | (2,474) | (7) | ||||||||||||
Change in fair value of warrants | — | (48,719) | ||||||||||||
Other income, net | 16 | 27 | ||||||||||||
Loss before income taxes | (93,032) | (129,651) | ||||||||||||
Income tax expense | (25) | (43) | ||||||||||||
Net loss | (93,057) | (129,694) | ||||||||||||
Other comprehensive income (loss): | ||||||||||||||
Foreign currency translation adjustment | (25) | 27 | ||||||||||||
Unrealized loss on marketable securities | (5,780) | — | ||||||||||||
Total comprehensive loss | $ | (98,862) | $ | (129,667) | ||||||||||
Net loss per share: | ||||||||||||||
Basic and diluted | $ | (0.36) | $ | (0.55) | ||||||||||
Weighted-average shares outstanding: | ||||||||||||||
Basic and diluted | 258,287,847 | 234,191,636 |
5
VIRGIN GALACTIC HOLDINGS, INC.
Condensed Consolidated Statements of Equity
(In thousands except for per unit and share data)
(Unaudited)
(For the periods ended March 31, 2022 and 2021)
Preferred Stock | Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||||
# of Shares | Par Value | # of Shares | Par Value | Additional paid-in capital | Accumulated Deficit | Accumulated Other Comprehensive Income (Loss) | Total | |||||||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2020 | — | $ | — | 236,123,659 | $ | 23 | $ | 1,297,794 | $ | (770,744) | $ | 5 | $ | 527,078 | ||||||||||||||||||||||||||||||||||||
Net loss | — | — | — | — | — | (129,694) | — | (129,694) | ||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | — | 26 | 26 | ||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 22,111 | — | — | 22,111 | ||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock pursuant to stock-based compensation, net of witholding taxes | — | — | 1,150,771 | — | 323 | — | — | 323 | ||||||||||||||||||||||||||||||||||||||||||
Balance as of March 31, 2021 | — | — | 237,274,430 | $ | 23 | $ | 1,320,228 | $ | (900,438) | $ | 31 | $ | 419,844 | |||||||||||||||||||||||||||||||||||||
Preferred Stock | Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||||
# of Shares | Par Value | # of Shares | Par Value | Additional paid-in capital | Accumulated Deficit | Accumulated Other Comprehensive Income (Loss) | Total | |||||||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2021 | — | $ | — | 258,166,417 | $ | 26 | $ | 2,019,750 | $ | (1,123,643) | $ | (1,869) | $ | 894,264 | ||||||||||||||||||||||||||||||||||||
Net loss | — | — | — | — | — | (93,057) | — | (93,057) | ||||||||||||||||||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | — | (5,805) | (5,805) | ||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 10,895 | — | — | 10,895 | ||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock pursuant to stock-based compensation, net of withholding taxes | — | — | 307,471 | — | (1,882) | — | — | (1,882) | ||||||||||||||||||||||||||||||||||||||||||
Purchase of capped calls | — | — | — | — | (52,318) | — | — | (52,318) | ||||||||||||||||||||||||||||||||||||||||||
Balance as of March 31, 2022 | — | — | 258,473,888 | $ | 26 | $ | 1,976,445 | $ | (1,216,700) | $ | (7,674) | $ | 752,097 | |||||||||||||||||||||||||||||||||||||
6
VIRGIN GALACTIC HOLDINGS, INC.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Three Months Ended March 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
Cash flows from operating activities | ||||||||||||||
Net loss | $ | (93,057) | $ | (129,694) | ||||||||||
Stock-based compensation | 10,895 | 22,111 | ||||||||||||
Depreciation and amortization | 2,852 | 2,869 | ||||||||||||
Amortization of debt issuance costs | 403 | — | ||||||||||||
Change in fair value of warrant liability | — | 48,719 | ||||||||||||
Other operating activities, net | 86 | 10 | ||||||||||||
Change in assets and liabilities | ||||||||||||||
Inventories | 201 | 296 | ||||||||||||
Other current and non-current assets | 2,282 | 3,692 | ||||||||||||
Accounts payable and accrued liabilities | 1,126 | 3,322 | ||||||||||||
Customer deposits | 9,228 | (196) | ||||||||||||
Other current and non-current liabilities | (67) | 102 | ||||||||||||
Net cash used in operating activities | (66,051) | (48,769) | ||||||||||||
Cash flows from investing activity | ||||||||||||||
Capital expenditures | (1,773) | (819) | ||||||||||||
Investment in marketable securities | (204,898) | — | ||||||||||||
Cash used in investing activity | (206,671) | (819) | ||||||||||||
Cash flows from financing activities | ||||||||||||||
Payments of finance lease obligations | (34) | (34) | ||||||||||||
Proceeds from convertible senior notes | 425,000 | — | ||||||||||||
Debt issuance costs | (11,248) | — | ||||||||||||
Purchase of capped calls | (52,318) | — | ||||||||||||
Proceeds from issuance of common stock pursuant to stock options exercised | 49 | 10,837 | ||||||||||||
Withholding taxes paid on behalf of employees on net settled stock-based awards | (1,932) | (10,514) | ||||||||||||
Net cash provided by financing activities | 359,517 | 289 | ||||||||||||
Net increase (decrease) in cash and cash equivalents | 86,795 | (49,299) | ||||||||||||
Cash, cash equivalents and restricted cash at beginning of period | 550,030 | 678,955 | ||||||||||||
Cash, cash equivalents and restricted cash at end of period | $ | 636,825 | $ | 629,656 | ||||||||||
Cash and cash equivalents | $ | 601,464 | $ | 616,625 | ||||||||||
Restricted cash | 35,361 | 13,031 | ||||||||||||
Cash, cash equivalents and restricted cash | $ | 636,825 | $ | 629,656 |
7
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
(1) Organization and its wholly owned subsidiaries ("VGH, Inc.")
Virgin Galactic Holdings, Inc. and its wholly owned subsidiaries ("VGH, Inc."), in this report as "we," "us," "our," the "Company" and similar terms, are focused on the development, manufacture and operations of spaceships and related technologies for the purpose of conducting commercial human spaceflight and flying commercial research and development payloads into space. The development and manufacturing activities are located in Tustin, California and Mojave, California, with plans to operate the commercial spaceflights out of Spaceport America located in New Mexico.
(2) Summary of Significant Accounting Policies
(a) Basis of Presentation
These condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). All intercompany transactions and balances between the various legal entities comprising the Company have been eliminated in consolidation.
Certain reclassifications of the components of operating loss have been made in the condensed consolidated statements of operations and comprehensive loss to conform to the current period presentation. Specifically, cost of revenue has been reclassified to customer experience, and gross margin is no longer presented. Customer experience expenses related to spaceflight operations include the consumption of a rocket motor and fuel and other consumables, as well as payroll and benefits for our pilots and ground crew. Customer experience expenses related to the payload cargo services, as well as engineering services, consist of materials and human capital, such as payroll and benefits, to perform these services. Additionally, customer experience expenses include costs associated with maintaining and growing our Future Astronaut community, as well as hospitality, medical, safety, security, training, and facility costs that are for the benefit of our astronauts. Additionally, depreciation and amortization expense are presented separately instead of included in selling, general, and administrative or research and development expenses. These reclassifications had no impact on total loss as previously reported.
(b) Use of Estimates
The preparation of the consolidated financial statements in conformity with GAAP required us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base these estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates. Significant estimates inherent in the preparation of the consolidated financial statements include, but are not limited to, accounting for revenue, contract assets, contract liabilities, useful lives of property, plant and equipment, fair value of investments, accrued liabilities, income taxes including deferred tax assets and liabilities and impairment valuation, warrants, stock-based awards and contingencies.
(c) Convertible Senior Notes
On January 1, 2022, the Company adopted ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which removes from GAAP the liability and equity separation model for convertible instruments with either cash or beneficial conversion features. As a result, convertible debt instruments would only be separated into multiple components if they were issued at a substantial premium or if embedded derivatives required bifurcation was identified. The notes were not issued at a substantial premium, and the Company analyzed the provisions of the notes and did not identify any material embedded features which would require bifurcation from the host debt. As such, the notes are accounted for entirely as a liability net of unamortized issuance costs. The carrying amount of the liability
8
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
is classified as long-term as the instrument does not mature within one year of the balance sheet date and the holder is not permitted to demand repayment of the principal within one year of the balance sheet date. However, if conditions to convertibility are met as described further in Note 11, the Company may be required to reclassify the carrying amount of the liability to current. The embedded conversion features are not remeasured as long as they do not meet the separation requirement of a derivative. Issuance costs are amortized on a straight-line basis, which approximates the effective interest rate method, to interest expense over the term of the notes. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share, however there was no impact during the current quarter as the convertible instruments were anti-dilutive.
(d) Capped Call Transactions
In connection with the pricing of our Convertible Senior Notes, the Company entered into capped call transactions with respect to its common stock (the "2027 Capped Calls"). The 2027 Capped Calls are purchased call options that give the Company the option to purchase, subject to anti-dilution adjustments substantially identical to those in the 2027 Notes. The Company's capped call transactions are accounted for as separate transactions from the convertible senior notes and are classified as equity instruments as a reduction to additional paid-in capital in the condensed consolidated balance sheets. The instruments are initially recorded at fair value and not subsequently remeasured so long as they continue to qualify for equity classification. The capped call transactions have the effect of reducing the number of shares outstanding if exercised. Therefore, the capped call transactions are anti-dilutive and not included in the calculation of diluted shares outstanding for the purposes of diluted net loss per share. See Note 11 in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional information on the 2027 Capped Calls.
(e) Other Summary of Significant Accounting Policies
There have been no other significant changes from the significant accounting policies disclosed in Note 2 of the “Notes to Consolidated Financial Statements” included in the Company's Annual Report on Form 10-K.
The interim financial information is unaudited, but reflects all normal recurring adjustments that are, in the opinion of management, necessary to fairly present the information set forth herein. The interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K. Interim results are not necessarily indicative of the results for a full year.
(3) Recent Accounting Pronouncements
Changes to GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASU”). See Note 2 in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional information on recently adopted accounting pronouncements.
(4) Related Party Transactions
The Company licenses its brand name from certain entities affiliated with Virgin Enterprises Limited (“VEL”), a company incorporated in England. VEL is an affiliate of the Company. Under the trademark license, the Company has the exclusive right to operate under the brand name “Virgin Galactic” worldwide. Royalty payables, excluding sponsorship royalties, for the use of license are the greater of 1% of revenue or $0.04 million per quarter, prior to the commercial launch date. Sponsorship royalties payable are 25% of sponsorship revenue. We paid license and royalty fees of $0.04 million and $0.04 million for the three months ended March 31, 2022 and 2021, respectively.
9
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The Company has a Transition Services Agreement ("TSA") with Virgin Orbit, LLC ("VO") based on an allocation methodology that considers our headcount, unless directly attributable to the business. The Company is allocated operating expenses from VO Holdings, Inc. and its subsidiaries (“VOH”), a majority-owned company of GV for operations-related functions based on an allocation methodology that considers our headcount, unless directly attributable to the business. Operating expense allocations include use of machinery and equipment, pilot services, and other general administrative expenses. We were allocated no operating expenses, net, from VOH for the three months ended March 31, 2022. We were allocated $40,000 of operating expenses, net, from VOH for the three months ended March 31, 2021. The Company has a receivable from VOH of $52,000 and $43,000 as of March 31, 2022 and December 31, 2021, respectively.
(5) Cash, Restricted Cash, Cash Equivalents and Marketable Securities
The amortized cost, unrealized gain (loss) and estimated fair value of the Company's cash equivalents and marketable securities as of March 31, 2022 and December 31, 2021 were as follows:
As of March 31, 2022 | |||||||||||||||||
Amortized Cost | Gross Unrealized Gains (Losses) | Fair Value | |||||||||||||||
(In thousands) | |||||||||||||||||
Cash, restricted cash and cash equivalents | |||||||||||||||||
Cash and restricted cash | $ | 67,161 | $ | — | $ | 67,161 | |||||||||||
Money market | 478,049 | — | 478,049 | ||||||||||||||
Certificate of deposits | 91,615 | — | 91,615 | ||||||||||||||
Marketable securities | |||||||||||||||||
US treasuries | 29,990 | 3 | 29,993 | ||||||||||||||
Corporate debt securities | 557,792 | (7,786) | 550,006 | ||||||||||||||
Total cash, cash equivalents and marketable securities | $ | 1,224,607 | $ | (7,783) | $ | 1,216,824 |
As of December 31, 2021 | |||||||||||||||||
Amortized Cost | Gross Unrealized Gains (Losses) | Fair Value | |||||||||||||||
(In thousands) | |||||||||||||||||
Cash, restricted cash and cash equivalents | |||||||||||||||||
Cash and restricted cash | $ | 55,592 | $ | — | $ | 55,592 | |||||||||||
Money market | 402,889 | — | 402,889 | ||||||||||||||
Certificate of deposits | 91,549 | — | 91,549 | ||||||||||||||
Marketable securities | |||||||||||||||||
Corporate debt securities | 382,884 | (2,003) | 380,881 | ||||||||||||||
Total cash, cash equivalents and marketable securities | $ | 932,914 | $ | (2,003) | $ | 930,911 |
The Company included $3.1 million and $2.3 million of interest receivable in prepaid expenses and other current assets as of March 31, 2022 and December 31, 2021, respectively.
10
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The Company recognized $2.2 million in amortization expense for marketable securities within interest income, net for the three months ended March 31, 2022. The Company did not recognize any amortization expense for the three months ended March 31, 2021.
The following table presents the contractual maturities of the Company's marketable securities as of March 31, 2022:
As of March 31, 2022 | |||||||||||
Amortized Cost | Estimated Fair Value | ||||||||||
(In thousands) | |||||||||||
Matures within one year | $ | 267,551 | $ | 265,857 | |||||||
Matures between one to two years | 320,231 | 314,142 | |||||||||
Total | $ | 587,782 | $ | 579,999 |
(6) Inventory
As of March 31, 2022 and December 31, 2021, inventory is comprised of the following:
As of | ||||||||||||||
March 31, 2022 | December 31, 2021 | |||||||||||||
(Unaudited) | ||||||||||||||
(In thousands) | ||||||||||||||
Raw Materials | $ | 20,648 | $ | 21,127 | ||||||||||
Spare parts | 8,819 | 8,541 | ||||||||||||
Total inventory | $ | 29,467 | $ | 29,668 |
For the three months ended March 31, 2022 and March 31, 2021, we wrote off $0.3 million and $0.1 million of inventory due to excess and obsolescence, respectively.
11
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
(7) Property, Plant, and Equipment, net
As of March 31, 2022 and December 31, 2021, property, plant, and equipment, net consisted of the following:
As of | ||||||||||||||
March 31, 2022 | December 31, 2021 | |||||||||||||
(Unaudited) | ||||||||||||||
(In thousands) | ||||||||||||||
Land | $ | 401 | $ | — | ||||||||||
Buildings | 9,117 | 9,117 | ||||||||||||
Leasehold improvements | 29,228 | 29,155 | ||||||||||||
Aircraft | 195 | 195 | ||||||||||||
Machinery and equipment | 38,189 | 37,002 | ||||||||||||
IT software and equipment | 25,370 | 23,523 | ||||||||||||
Construction in progress | 2,189 | 2,901 | ||||||||||||
104,689 | 101,893 | |||||||||||||
Less accumulated depreciation and amortization | (57,213) | (54,395) | ||||||||||||
Property, plant, and equipment, net | $ | 47,476 | $ | 47,498 |
The following table sets forth the summary of depreciation and amortization expense for property, plant and equipment, net:
Three Months Ended March 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(Unaudited) | ||||||||||||||
(In thousands) | ||||||||||||||
Customer experience | $ | — | $ | — | ||||||||||
Selling, general, and administrative | 1,599 | 1,595 | ||||||||||||
Research and development | 1,253 | 1,274 | ||||||||||||
$ | 2,852 | $ | 2,869 |
(8) Leases
The Company's leases are more fully described in Note 8 of the "Notes to Consolidated Financial Statements" to its Annual Report on Form 10-K.
12
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The components of lease expense related to leases for the periods presented below are as follows:
Three Months Ended March 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(Unaudited and in thousands) | ||||||||||||||
Lease Cost: | ||||||||||||||
Operating lease expense | $ | 1,975 | $ | 1,260 | ||||||||||
Short-term lease expense | — | 12 | ||||||||||||
Finance Lease Cost: | ||||||||||||||
Amortization of right-of-use assets | 29 | 34 | ||||||||||||
Interest on lease liabilities | 5 | 7 | ||||||||||||
Total finance lease cost | 34 | 41 | ||||||||||||
Variable lease cost | 1,249 | 1,338 | ||||||||||||
Total lease cost | $ | 3,258 | $ | 2,651 |
13
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The components of supplemental cash flow information related to leases for the period are as follows:
Three Months Ended March 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(In thousands, except term and rate data) | ||||||||||||||
Cash flow information: | ||||||||||||||
Operating cash flows for operating leases | $ | 1,758 | $ | 1,310 | ||||||||||
Operating cash flows for finance leases | $ | 5 | $ | 7 | ||||||||||
Financing cash flows for finance leases | $ | 34 | $ | 34 | ||||||||||
Non-cash activity: | ||||||||||||||
Right-of-use assets obtained in exchange for lease obligations | ||||||||||||||
Operating leases | $ | 502 | $ | 180 | ||||||||||
Other Information: | ||||||||||||||
Weighted average remaining lease term: | ||||||||||||||
Operating leases (in years) | 11.46 | 12.53 | ||||||||||||
Finance leases (in years) | 1.90 | 2.66 | ||||||||||||
Weighted average discount rates: | ||||||||||||||
Operating leases | 11.67 | % | 11.68 | % | ||||||||||
Finance leases | 8.13 | % | 8.40 | % |
The supplemental balance sheet information related to leases for the period is as follows:
As of | ||||||||||||||
March 31, 2022 | December 31, 2021 | |||||||||||||
(Unaudited) | ||||||||||||||
(In thousands) | ||||||||||||||
Operating leases | ||||||||||||||
Long-term right-of-use assets | $ | 35,178 | $ | 35,486 | ||||||||||
Short-term operating lease liabilities | $ | 2,104 | $ | 2,204 | ||||||||||
Long-term operating lease liabilities | 39,974 | 39,965 | ||||||||||||
Total operating lease liabilities | $ | 42,078 | $ | 42,169 |
Commitments
The Company has certain non-cancelable operating leases primarily for its premises. These leases generally contain renewal options for periods ranging from 3 to 20 years and require the Company to pay all executory costs, such as maintenance and insurance. Certain lease arrangements have rent free periods or escalating payment provisions, and we recognize rent expense of such arrangements on a straight line basis.
14
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Future minimum lease payments under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) and future minimum finance lease payments as of March 31, 2022 are as follows:
Operating Leases | Finance Leases | |||||||||||||
(In thousands) | ||||||||||||||
2022 (for the remaining period) | $ | 4,810 | $ | 98 | ||||||||||
2023 | 6,435 | 106 | ||||||||||||
2024 | 6,766 | 31 | ||||||||||||
2025 | 6,675 | — | ||||||||||||
2026 | 6,760 | — | ||||||||||||
Thereafter | 47,710 | — | ||||||||||||
Total lease payments | $ | 79,156 | $ | 235 | ||||||||||
Less: | ||||||||||||||
Imputed interest/present value discount | $ | (37,078) | $ | (17) | ||||||||||
Present value of lease liabilities | $ | 42,078 | $ | 218 |
(9) Accrued Expenses
A summary of the components of accrued liabilities are as follows:
As of | ||||||||||||||
March 31, 2022 | December 31, 2021 | |||||||||||||
(Unaudited) | ||||||||||||||
(In thousands) | ||||||||||||||
Accrued payroll | $ | 6,084 | $ | 4,214 | ||||||||||
Accrued vacation | 5,556 | 5,372 | ||||||||||||
Accrued bonus | 5,226 | 12,218 | ||||||||||||
Accrued interest expense | 2,067 | — | ||||||||||||
Other accrued expenses | 11,619 | 6,983 | ||||||||||||
Total accrued expenses | $ | 30,552 | $ | 28,787 |
15
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
(10) Commercial Loan
As of | |||||||||||||||||
March 31, 2022 | December 31, 2021 | ||||||||||||||||
(Unaudited) | |||||||||||||||||
(In thousands) | |||||||||||||||||
Commercial loan | $ | 310 | $ | 310 | |||||||||||||
Less: Current portion | (310) | (310) | |||||||||||||||
Non-current portion | $ | — | $ | — |
Commercial Loan
On June 18, 2020, we financed the purchase of software licenses through a loan totaling approximately $0.9 million. The loan amortized in three equal annual installments of approximately $0.3 million with the final payment due on October 1, 2022 with 0% interest rate. The loan is secured by a standby letter of credit issued from our financial institution and restricted cash has been recorded for the corresponding outstanding balance. The outstanding balance is recorded in other current-liabilities on the condensed consolidated balance sheets.
The imputed interest of this loan was immaterial.
(11) Convertible Senior Notes
2027 Convertible Senior Notes
On January 19, 2022, the Company completed an offering of $425 million aggregate principal amount of convertible senior notes (the "2027 Notes"). The 2027 Notes are senior, unsecured obligations of the Company, and bear interest at a fixed rate of 2.50% per year. Interest is payable in cash semi-annually in arrears on February 1 and August 1 of each year, beginning on August 1, 2022. The 2027 Notes mature on February 1, 2027 unless earlier repurchased, redeemed or converted.
The terms of the 2027 Notes are governed by an Indenture by and between the Company and UBS, as Trustee (the "2027 Indenture"). Upon conversion, the 2027 Notes may be settled in cash, shares of the Company's common stock or a combination of cash and shares of common stock, par value $0.0001 per share (the “common stock”), at our election, based on the conversion rate.
The 2027 Notes are convertible at an initial conversion rate of 78.1968 shares of common stock per $1,000 principal amount of the 2027 Notes, which is equal to an initial conversion price of approximately $12.79 per share of common stock, subject to adjustment upon the occurrence of certain events. Noteholders will have the right to convert their notes during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on June 30, 2022, under the following circumstances:
•during any calendar quarter after June 30, 2022 (and only during such calendar quarter) if the closing price of the Company's common stock for at least 20 trading days in a period of 30 consecutive trading days ending
16
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
on and including the last trading day of the preceding calendar quarter is more than 130% of the then applicable conversion price for the Notes per share of common stock;
•during the five business days immediately after any ten consecutive trading day period in which the trading price per $1,000 principal amount of 2027 Notes for each day of that period was less than 98% of the product of the closing price of our common stock and the then applicable conversion rate;
•the Company calls any or all of the 2027 Notes for redemption, holders may convert all or any portion of their notes at any time prior to the close of business on the scheduled trading day prior to the redemption date, even if the 2027 Notes are not otherwise convertible at such time; or
•specified distributions to holders of our common stock are made or specified corporate events occur, as described in the 2027 Indenture.
On and after November 1, 2026, noteholders will have the right to convert their notes at any time at their election until the close of business on the second scheduled trading day immediately before the maturity date. During the three months ended March 31, 2022, the conditions allowing holders of the 2027 Notes to convert during the three months ending March 31, 2022 were not met, and as a result, the 2027 Notes were classified as noncurrent liabilities as of March 31, 2022.
The 2027 Notes will be redeemable, in whole or in part (subject to certain limitations), for cash at the Company's option at any time, and from time to time, on or after February 6, 2025 and on or before the 20th scheduled trading day immediately before the maturity date, but only if the last reported sale price per share of the Company's common stock exceeds 130% of the conversion price for a specified period of time and certain liquidity conditions have been satisfied. The redemption price will be equal to the principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. During the three months ended March 31, 2022, the Company did not redeem any of the 2027 Notes.
Holders of the 2027 Notes who convert their 2027 Notes in connection with certain corporate events that constitute a make-whole fundamental change (as defined in the 2027 Indenture) or in connection with the Company's issuance of a redemption notice are, under certain circumstances, entitled to an increase in the conversion rate. Additionally, in the event of a corporate event that constitutes a fundamental change (as defined in the 2027 Indenture), holders of the 2027 Notes may require the Company to repurchase all or a portion of their 2027 Notes at a price equal to 100% of the principal amount of the 2027 Notes being repurchased, plus any accrued and unpaid interest.
The 2027 Notes, net consisted of the following (in thousands):
As of | ||||||||
March 31, 2022 | ||||||||
(Unaudited) | ||||||||
Principal | $ | 425,000 | ||||||
Less: unamortized debt issuance costs | (10,845) | |||||||
Net carrying amount | $ | 414,155 |
As of March 31, 2022, we recorded $2.1 million of accrued interest expense on our 2027 Notes within accrued expenses. For the three months ended March 31, 2022, we recognized 2.5 million of total interest expense on our 2027 Notes, including $0.4 million of amortized debt issuance costs.
Capped Call Transactions
17
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
In connection with the pricing of the 2027 Notes, the Company entered into capped call transactions with respect to its common stock. The 2027 Capped Calls are purchased call options that give the Company the option to purchase, subject to anti-dilution adjustments substantially identical to those in the 2027 Notes, approximately 33 million shares of its common stock for approximately $12.79 per share (subject to adjustment), corresponding to the approximate initial conversion price of the 2027 Notes, exercisable upon conversion of the 2027 Notes. The 2027 Capped Calls have initial cap prices of $20.06 per share (subject to adjustment), which represents a premium of 100% over the closing price of the Company's common stock on January 13, 2022, and will expire in 2027, if not exercised earlier. The 2027 Capped Calls are intended to offset potential dilution to the Company's common stock and/or offset the potential cash payments that the Company could be required to make in excess of the principal amount upon any conversion of the 2027 Notes under certain circumstances. The 2027 Capped Calls are separate transactions and are not part of the terms of the 2027 Notes.
The Company paid an aggregate amount of $52.3 million for the 2027 Capped Calls. As these transactions meet certain accounting criteria, the amount paid for the 2027 Capped Calls was recorded as a reduction to additional paid-in capital in the condensed consolidated balance sheets. The fair value of the 2027 Capped Calls is not remeasured each reporting period so long as they continue to qualify for equity classification, which they did for the current period.
(12) Income Taxes
Income tax expense was $0.03 million and $0.04 million for the three months ended March 31, 2022 and 2021, respectively. The effective income tax rate was nil for three months ended March 31, 2022 and 2021. Our effective tax rate differs from the U.S. statutory rate primarily due to a substantially full valuation allowance against our net deferred tax assets where it is more likely than not that some or all of the deferred tax assets will not be realized.
(13) Stockholders' Equity
There have been no significant changes from the Stockholders' Equity disclosed in Note 12 of the “Stockholders Equity” included in our Annual Report on Form 10-K.
Stockholders' Agreement
In connection with the closing of the Virgin Galactic Business Combination, the Company entered into a stockholders’ agreement with certain of the Company’s investors. Pursuant to the terms of the Stockholders’ Agreement, as long as Virgin Investments Limited ("VIL") is entitled to designate two directors to the Company’s Board of Directors, the Company must obtain VIL’s prior written consent to engage in certain corporate transactions and management functions such as business combinations, disposals, acquisitions, incurring indebtedness, and engagement of professional advisors, among others.
Warrants and Warrant Redemption
Public and private placement warrants were initially issued as part of Social Capital Hedosophia Holdings Corp.'s ("SCH") initial public offering in 2017 and assumed upon the consumption of the Business Combination. As of March 31, 2022, and December 31, 2021, there were no public or private placement warrants outstanding.
The Company remeasured the fair value of the Warrants at each reporting date with changes recorded in earnings. In connection with the Company's remeasurement of the Warrants to fair value, the Company recorded expense of approximately $(48.7) million for the three months ended March 31, 2021.
At The Market Offering
On July 12, 2021, the Company entered into a distribution agency agreement with Credit Suisse Securities (USA) LLC, Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC (each, an “Agent” and collectively, the “Agents”) providing for the offer and sale of up to $500.0 million of shares of the Company’s common stock, par
18
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
value $0.0001 per share, through an "at the market offering" program ("ATM"), from time to time by the Company through the Agents, acting as the Company’s sales agents, or directly to one or more of the Agents, acting as principal.
On July 16, 2021, we completed the ATM, generating $500.0 million in gross proceeds, before deducting $6.2 million in underwriting discounts and commissions, and other expenses payable by the Company, through the sale of 13,740,433 shares of common stock.
(14) Net Loss Per Share
The following table presents net loss per share and related information:
Three Months Ended March 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(In thousands, except for share and per share data) | ||||||||||||||
Basic and diluted: | ||||||||||||||
Net loss | $ | (93,057) | $ | (129,694) | ||||||||||
Weighted average shares of common stock outstanding | 258,287,847 | 234,191,636 | ||||||||||||
Basic and diluted net loss per share | $ | (0.36) | $ | (0.55) |
Basic and diluted loss per share is computed using the weighted-average number of common shares of common stock outstanding during the period. Basic net loss per share is the same as diluted net loss per share as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculation because they would be anti-dilutive were as follows (in thousands):
As of March 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
Issued and outstanding stock options | 4,242 | 5,430 | ||||||||||||
Issued and outstanding performance stock options | 406 | — | ||||||||||||
Unvested restricted stock units issued and outstanding | 3,906 | 4,158 | ||||||||||||
Unvested performance stock units issued and outstanding | 367 | — | ||||||||||||
Shares related to the 2027 Notes (1) | 33,234 | — | ||||||||||||
Warrants to purchase shares of common stock | — | 8,000 | ||||||||||||
42,155 | 17,588 |
(1) The Company uses the if-converted method for calculating any potential dilutive effect of the conversion options embedded in the 2027 Notes on diluted net loss per share, if applicable.
(15) Stock-Based Compensation
The Company's 2019 Incentive Award Plan ("2019 Plan") is more fully described in Note 14 of the "Notes to Consolidated Financial Statements" on Form 10-K. Under the 2019 Plan, the Company has the ability to grant incentive stock options, non-qualified stock options and restricted stock units ("RSUs") to employees, directors and other service providers. Performance stock units ("PSUs") are RSUs that vest based on achievement of specified
19
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
performance criteria. Performance stock options ("PSOs") are stock options that vest based on achievement of specified performance criteria.
Stock Options
Twenty five percent of such stock options cliff vest at the grant date first anniversary and will vest ratably over the next three years, subject to continued employment on each vesting date. Vested options will be exercisable at any time until ten years from the grant date, subject to earlier expiration under certain terminations of service and other conditions. The stock options granted have an exercise price equal to the closing stock price of our common stock on the grant date.
In 2022, we issued stock options as incentive compensation for certain key employees. The fair values of these stock options were estimated using a Black-Scholes model with the following assumptions:
2022 | ||||||||
Expected life (in years)(1) | 6.11 | |||||||
Expected volatility(2) | 69.0 | % | ||||||
Risk free interest rate(3) | 2.19 | % | ||||||
Dividend yield(4) | — | % |
(1) The expected life is the period of time that participants are expected to hold their options before exercised using the "simplified method" as described in Staff Accounting Bulletin No. 107.
(2) The expected volatility is a measure of the amount by which a stock price is expected to fluctuate based primarily on our and our peers' historical data.
(3) The risk-free interest rate for the periods within the contractual term of the options is based on the U.S. Treasury yield curve in effect at the time of the grant.
(4) The Company does not currently pay dividends nor has announced plans to begin paying dividends.
20
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The following table sets forth the summary of options activity under the 2019 Plan (dollars in thousands except per share data):
Number of Shares | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life (in years) | Aggregate Intrinsic Value(1) | Weighted Average Grant Date Fair Value ($) | ||||||||||||||||||||||||||||
Options outstanding at December 31, 2021 | 4,253,767 | $ | 14.09 | 7.60 | $ | 6,187 | ||||||||||||||||||||||||||
Granted | 303,030 | 7.99 | 4.95 | |||||||||||||||||||||||||||||
Exercised | (4,182) | 11.79 | ||||||||||||||||||||||||||||||
Forfeited options | (310,586) | 19.98 | ||||||||||||||||||||||||||||||
Options outstanding at March 31, 2022 | 4,242,029 | $ | 13.23 | 7.79 | $ | 1,238 | ||||||||||||||||||||||||||
Options exercisable at March 31, 2022 | 1,957,167 | $ | 12.94 | 7.49 | $ | 348 | ||||||||||||||||||||||||||
__________________ |
(1) Aggregate intrinsic value is calculated based on the difference between our closing stock price at period end and the exercise price, multiplied by the number of in-the-money options and represents the pre-tax amount that would have been received by the option holders, had they all exercised all their options on the period end date.
Performance Stock Options
Compensation expense on the PSOs will be recognized over the period between the grant date and the estimated vest date. The number of PSOs that will vest depends on the attainment of certain stock price goals. Vested options will be exercisable at any time until ten years from the grant date, subject to earlier expiration under certain terminations of service and other conditions. The stock options granted have an exercise price equal to the closing stock price of our common stock on the grant date.
In 2022, we issued PSOs as incentive compensation for certain key employees. The fair values of these stock options were estimated using a Monte-Carlo simulation with the following assumptions:
Expected exercise behavior(1) | 75.0 | % | ||||||
Expected Volatility(2) | 58.0 | % | ||||||
Risk free interest rate(3) | 2.19 | % | ||||||
Dividend yield(4) | — | % |
(1) PSOs are expected to be exercised after 75% of the period between the vest date and the end of the contractual term has lapsed.
(2) The expected volatility is a measure of the amount by which a stock price is expected to fluctuate based primarily on our and our peers' historical data.
(3) The risk-free interest rate for the periods within the contractual term of the options is based on the U.S. Treasury yield curve in effect at the time of the grant.
(4) The Company does not currently pay dividends nor has announced plans to begin paying dividends.
21
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The following table sets forth the summary of PSO activity under the 2019 Plan (dollars in thousands except per share data):
Number of Shares | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life (in years) | Aggregate Intrinsic Value(1) | Weighted Average Grant Date Fair Value ($) | ||||||||||||||||||||||||||||
PSOs outstanding at December 31, 2021 | — | $ | — | 0.0 | $ | — | ||||||||||||||||||||||||||
Granted | 405,680 | 8.99 | 4.93 | |||||||||||||||||||||||||||||
Exercised | — | — | ||||||||||||||||||||||||||||||
Forfeited options | — | — | ||||||||||||||||||||||||||||||
PSOs outstanding at March 31, 2022 | 405,680 | $ | 8.99 | 9.96 | $ | 361 | ||||||||||||||||||||||||||
PSOs exercisable at March 31, 2022 | — | $ | — | 0.0 | $ | — | ||||||||||||||||||||||||||
__________________ |
(1) Aggregate intrinsic value is calculated based on the difference between our closing stock price at period end and the exercise price, multiplied by the number of in-the-money options and represents the pre-tax amount that would have been received by the option holders, had they all exercised all their options on the period end date.
Restricted Stock Units
The RSUs primarily vest over four years with 25% cliff vest at the first year anniversary of the grant date and ratably over the next three years.
The following table sets forth the summary of RSUs activity under the 2019 Plan (dollars in thousands except per share data):
Shares | Weighted Average Fair Value | |||||||||||||
Outstanding at December 31, 2021 | 2,396,732 | $ | 27.89 | |||||||||||
Granted | 2,121,020 | 8.79 | ||||||||||||
Vested | (497,699) | 21.96 | ||||||||||||
Forfeited | (114,494) | 20.77 | ||||||||||||
Outstanding at March 31, 2022 | 3,905,559 | $ | 16.26 |
Performance Stock Units
Between 25% and 200% of the PSUs are eligible to vest based on the achievement of certain performance-based goals or market-based goals by specified target dates, subject to continued service through the applicable vesting date. PSUs with performance-based goals are amortized over the requisite service period in which it is probable that the performance goal is achieved. PSUs with market-based goals will vest based on the Company's common stock performance following the end of the three year performance measurement period based on the highest closing price over twenty consecutive trading days during the performance measurement period. PSUs with market-based goals cannot vest before the end of the performance measurement period, thus the requisite service period is three years.
22
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
In 2022, we issued PSUs as incentive compensation for certain key employees. The fair values of these stock units were estimated using a Monte-Carlo simulation with the following assumptions:
Expected volatility(1) | 95.0 | % | ||||||
Risk free interest rate(2) | 2.13 | % | ||||||
Dividend yield(3) | — | % |
(1) The expected volatility is a measure of the amount by which a stock price is expected to fluctuate based primarily on our and our peers' historical data.
(2) The risk-free interest rate for the periods within the contractual term of the options is based on the U.S. Treasury yield curve in effect at the time of the grant.
(3) The Company does not currently pay dividends nor has announced plans to begin paying dividends.
The following table summarizes the details of the PSUs:
Shares | Weighted Average Fair Value | |||||||||||||
PSUs outstanding at December 31, 2021 | 89,839 | $ | 26.47 | |||||||||||
Granted | 277,552 | 14.62 | ||||||||||||
Forfeited | — | — | ||||||||||||
PSUs outstanding at March 31, 2022 | 367,391 | $ | 18.19 |
Stock-based compensation expense was recorded in the following expense categories in the condensed consolidated statements of operations and comprehensive loss:
Three Months Ended March 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(in thousands) | ||||||||||||||
Stock option expense | ||||||||||||||
Customer experience | $ | — | $ | — | ||||||||||
Selling, general and administrative | 1,722 | 8,986 | ||||||||||||
Research and development | 689 | 843 | ||||||||||||
Total stock option expense | 2,411 | 9,829 | ||||||||||||
RSU expense | ||||||||||||||
Customer experience | — | — | ||||||||||||
Selling, general and administrative | 5,555 | 9,052 | ||||||||||||
Research and development | 2,929 | 3,230 | ||||||||||||
Total RSU expense | 8,484 | 12,282 | ||||||||||||
Total stock-based compensation expense | $ | 10,895 | $ | 22,111 |
As of March 31, 2022, the unrecognized stock-based compensation related to these options was $23.6 million, of which $1.9 million is related to PSOs, and is expected to be recognized over a weighted-average period of 2.1 years.
23
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
At March 31, 2022, the unrecognized stock-based compensation related to RSUs was $100.4 million, of which $8.0 million is related to PSUs, and is expected to be recognized over a weighted-average period of 2.9 years.
(16) Fair Value Measurements
We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. We estimate fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which is categorized in one of the following levels:
•Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the
reporting entity at the measurement date;
•Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability; and
•Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date.
The carrying amounts included in the condensed consolidated balance sheets under current assets and current liabilities approximate fair value because of the short maturity of these instruments. The following tables summarize the fair value of assets that are recorded in the Company’s condensed consolidated balance sheets as of March 31, 2022 and December 31, 2021 at fair value on a recurring basis:
Fair Value Measurements as of March 31, 2022 | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Assets | |||||||||||||||||||||||
Money market | $ | 478,049 | $ | — | $ | — | $ | 478,049 | |||||||||||||||
Certificate of deposit | 91,615 | — | — | 91,615 | |||||||||||||||||||
US treasuries | 29,993 | 29,993 | |||||||||||||||||||||
Corporate debt securities | — | 550,006 | — | 550,006 | |||||||||||||||||||
Total assets at fair value | $ | 569,664 | $ | 579,999 | $ | — | $ | 1,149,663 | |||||||||||||||
Liabilities | |||||||||||||||||||||||
2027 Notes | $ | — | $ | 411,549 | $ | — | $ | 411,549 | |||||||||||||||
Total liabilities at fair value | $ | — | $ | 411,549 | $ | — | $ | 411,549 |
The estimated fair value of the 2027 Notes were determined based on the quoted bid prices of the 2027 Notes in an over-the-counter market on the last trading day of the reporting period.
24
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Fair Value Measurements as of December 31, 2021 | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Assets | |||||||||||||||||||||||
Money market | $ | 402,889 | $ | — | $ | — | $ | 402,889 | |||||||||||||||
Certificate of deposit | 91,549 | — | — | 91,549 | |||||||||||||||||||
Corporate debt securities | — | 380,881 | — | 380,881 | |||||||||||||||||||
Total asset at fair value | $ | 494,438 | $ | 380,881 | $ | — | $ | 875,319 |
(17) Commitments and Contingencies
Legal Proceedings
From time to time, the Company is a party to various lawsuits, claims and other legal proceedings that arise in the ordinary course of business. The Company applies accounting for contingencies to determine when and how much to accrue for and disclose related to legal and other contingencies. Accordingly, the Company discloses contingencies deemed to be reasonably possible and accrues loss contingencies when, in consultation with legal advisors, it is concluded that a loss is probable and reasonably estimable. Although the ultimate aggregate amount of monetary liability or financial impact with respect to these matters is subject to many uncertainties and is therefore not predictable with assurance, management believes that any monetary liability or financial impact to the Company from these matters, individually and in the aggregate, beyond that provided at March 31, 2022, would not be material to the Company’s financial position, results of operations or cash flows. However, there can be no assurance with respect to such result, and monetary liability or financial impact to the Company from legal proceedings, lawsuits and other claims could differ materially from those projected.
Lavin v. the Company
On May 28, 2021, a class action complaint was filed against us in the Eastern District of New York captioned Lavin v. Virgin Galactic Holdings, Inc., Case No. 1:21-cv-03070. In September 2021, the Court appointed Robert Scheele and Mark Kusnier as co-lead plaintiffs for the purported class. Co-lead plaintiffs amended the complaint in December 2021, asserting violations of Sections 10(b), 20(a) and 20A of the Exchange Act of 1934 against us and certain of our current and former officers and directors on behalf of a putative class of investors who purchased our common stock between July 10, 2019 and October 14, 2021. The amended complaint alleges, among other things, that we and certain of our current and former officers and directors made false and misleading statements and failed to disclose certain information regarding the safety of its ships and success of its commercial flight program. Co-lead plaintiffs seek damages, interest, costs, expenses, attorneys' fees, and other unspecified equitable relief. The Company intends to vigorously defend against this matter.
Spiteri and Grenier, derivatively on behalf of the Company vs. Certain Current and Former Officers and Directors
On February 21, 2022 and March 1, 2022, two alleged shareholders filed separate derivative complaints purportedly on behalf of the Company against certain of our current and former officers and directors in the Eastern District of New York captioned Spiteri v. Branson et al., Case No. 1:22-cv-00933, and Grenier v. Branson et al., Case No. 1:22-cv-01100, respectively. The complaints assert violations of Sections 10(b), 14(a), and 21D of the Exchange Act of 1934 and claims of breach of fiduciary duty, aiding and abetting breach of fiduciary duty, abuse of control, gross mismanagement, waste of corporate assets, and unjust enrichment arising from substantially similar allegations as those contained in the securities class action described above. The complaints seek an unspecified sum of damages, interest, restitution, expenses, attorneys’ fees and other equitable relief. The cases are at a preliminary stage.
Shareholder Litigation Demand
25
VIRGIN GALACTIC HOLDINGS, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
On April 4, 2022, the Company received a litigation demand from an alleged shareholder requesting that the Company take legal action against certain of our current and former officers and directors for breach of fiduciary duty and insider trading arising from substantially similar allegations as those contained in the securities class action described above. The Company is evaluating the litigation demand.
(18) Employee Benefit Plan
The Company has defined contribution plans, under which the Company pays fixed contributions into a separate entity, and additional contributions to the plans are based upon a percentage of the employees’ elected contributions. The Company will have no legal or constructive obligation to pay further amounts. Obligations for contributions to defined contribution plans are recognized within selling, general, and administrative expenses and research and development in the condensed consolidated statements of operations and comprehensive loss, as incurred. Defined contributions were $1.5 million and $1.1 million for the three months ended March 31, 2022 and 2021, respectively.
(19) Supplemental Cash Flow Information
Three Months Ended March 30, | ||||||||||||||
2022 | 2021 | |||||||||||||
(in thousands) | ||||||||||||||
Supplemental disclosure | ||||||||||||||
Cash (payments) and refunds for: | ||||||||||||||
Income tax refund | $ | 10 | $ | — | ||||||||||
Income tax paid | (17) | (52) | ||||||||||||
$ | (7) | $ | (52) | |||||||||||
Schedule for noncash investing activities | ||||||||||||||
Unpaid property, plant, and equipment received | $ | 1,115 | $ | 186 | ||||||||||
$ | 1,115 | $ | 186 | |||||||||||
Schedule for noncash financing activities | ||||||||||||||
Issuance of common stock through RSUs vested | $ | 4,949 | $ | 22,825 | ||||||||||
$ | 4,949 | $ | 22,825 |
26
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Unless the context otherwise requires, all references in this section to the “Company,” "Virgin Galactic," “we,” “us,” or “our” refer to the business of the Virgin Galactic Companies and their subsidiaries prior to the consummation of the Virgin Galactic Business Combination and Virgin Galactic Holdings, Inc. and its subsidiaries after consummation of the Virgin Galactic Business Combination. Prior to the Virgin Galactic Business Combination and prior to the series of Vieco 10 reorganization steps, Galactic Ventures, LLC ("GV"), a wholly-owned subsidiary of Vieco 10, was the direct parent of the Virgin Galactic Companies.
You should read the following discussion and analysis of our financial condition and results of operations together with the condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q, as well as the audited financial statements and the related notes thereto, and the discussion under “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” and “Business” included in our Annual
Report on Form 10-K. This discussion contains forward-looking statements that reflect our plans, estimates, and beliefs that involve risks and uncertainties. As a result of many factors, such as those set forth under the “Risk Factors” section of our
our Annual Report on Form 10-K and under the "Cautionary Note Regarding Forward-Looking Statements" section and elsewhere in this Quarterly Report on Form 10-Q, our actual results may differ materially from those anticipated in these forward-looking statements.
Overview
We are at the vanguard of a new industry, pioneering a consumer space experience using reusable spaceflight systems. We believe the commercial exploration of space represents one of the most exciting and important technological initiatives of our time. Approximately 620 humans have ever traveled above the Earth’s atmosphere into space. This industry is growing dramatically due to new products, new sources of private and government funding, and new technologies. Demand is emerging from new sectors and demographics, which we believe is broadening the total addressable market. As government space agencies have retired or reduced their capacity to send humans into space, private companies are beginning to make exciting inroads into the fields of human space exploration. We have embarked on this journey with a mission to put humans and research experiments into space and return them safely to Earth on a routine and consistent basis. We believe that opening access to space will connect the world to the wonder and awe created by space travel, offering customers a transformative experience, and providing the foundation for a myriad of exciting new industries.
We are an aerospace and space travel company offering access to space for private individuals, researchers and government agencies. Our missions include flying passengers to space as tourists, as well as flying scientific payloads and researchers to space in order to conduct experiments for scientific and educational purposes. Our operations include the design and development, manufacturing, ground and flight testing, and post-flight maintenance of our spaceflight system vehicles. Our spaceflight system is developed using our proprietary technology and processes and is focused on providing space experiences for private astronauts, researcher flights and professional astronaut training.
We intend to offer our customers a unique, multi-day experience culminating in a spaceflight that includes several minutes of weightlessness and views of Earth from space. Our elegant and distinctive spaceflight system – which takes off and lands on a runway – has been designed for optimal safety and comfort. As part of our commercial operations, we have exclusive access to the Gateway to Space facility at Spaceport America located in New Mexico. Spaceport America is the world’s first purpose-built commercial spaceport and will be the site of our initial commercial spaceflight operations. We believe the site provides us with a competitive advantage as it has a desert climate with relatively predictable weather conditions preferable to support our spaceflights and it also has airspace that is restricted for surrounding general air traffic which facilitates frequent and consistent flight scheduling.
Our near-term focus is to launch the commercial program for human spaceflight. In December 2018, we made history by flying our groundbreaking spaceship, VSS Unity, to space. This represented the first flight of a spaceflight system built for commercial service to take humans into space. In February 2019, we flew our second spaceflight with VSS Unity, which carried a crew member in the cabin in addition to the two pilots. After relocating our operations to Spaceport America, we have flown an additional two spaceflights in May and July of 2021. The May 2021 flight carried revenue-generating research experiments as part of NASA’s Flight Opportunities Program. This is the third time Virgin Galactic has flown technology experiments in the cabin on a spaceflight. This flight also completed the data submission to the FAA resulting in the approval for the expansion of our commercial space transportation operator license to allow for the carriage of space flight participants.
27
This marked the first time the FAA licensed a spaceline to fly customers and was further validation of the inherent safety of our system.
Our flight in July 2021 was the 22nd flight of VSS Unity, the fourth rocket powered spaceflight and the first spaceflight with a full crew of four mission specialists in the cabin, including our Founder, Sir Richard Branson.
We believe that the market for commercial human spaceflight is significant and untapped. As of April 30, 2022, we received reservations for approximately 800 spaceflight tickets and collected approximately $101.8 million in deposits from future astronauts. With each ticket purchased, future astronauts will experience a multi-day journey to prepare their mind and body for their upcoming flight, which includes a comprehensive spaceflight training preparation program and culminates with a trip to space on the final day. Each ticket purchased after our ticket sale reopening in 2021 also includes a membership in Virgin Galactic's Future Astronaut community. This membership provides access to events and experiences, including exclusive weeks 'at home' with Virgin Galactic Astronaut 001, Sir Richard Branson.
Following the Company's formation in 2004, we have developed an extensive set of integrated aerospace development capabilities encompassing preliminary vehicle design and analysis, detail design, manufacturing, ground testing, flight testing, and maintenance of our spaceflight system. Our fully reusable spaceflight system consists of two primary components: our carrier aircraft, the mothership, and our spaceship.
Our mothership is a twin-fuselage, custom-built aircraft designed to carry the spaceship up to an altitude of approximately 45,000 feet where it is released for its flight into space. Using the mothership’s air launch capability, rather than a standard ground-launch, reduces the energy requirements of our spaceflight system as the spaceship does not have to ascend through the higher density atmosphere closest to the Earth’s surface. It is also a fully reusable part of our spaceflight system. The spaceship is a vehicle with the capacity to carry pilots and private astronauts, research experiments, and researchers that travel with their experiments for human tended research flights into space and return them safely to Earth. It is powered by a hybrid rocket propulsion system, which propels the spaceship on a trajectory into space. The hybrid rocket motor utilizes liquid oxidizer and solid fuel and is designed to be a simple, safe, reliable propulsion system for the spaceship. The spaceship’s cabin has been designed to maximize the future astronaut’s safety, experience and comfort. A dozen windows line the sides and ceiling of the spaceship, offering customers the ability to view the blackness of space as well as stunning views of the Earth below.
Our team is currently in various stages of designing, testing and manufacturing additional spaceships and rocket motors in order to meet the expected demand for human spaceflight experiences. Our next generation spaceships will include the various learnings from our flight test program so we are able to design and manufacture our future spaceships to allow for greater predictability, faster turnaround time and easier maintenance. Concurrently, we are also researching and developing new products and technologies to grow our company.
Our operations also include spaceflight opportunities for research and technology development. Prior to Virgin Galactic’s offering, researchers have utilized parabolic aircraft and drop towers to create moments of microgravity and conduct significant research activities related to the space environment. In most cases, these solutions offer only seconds of continuous microgravity time and do not offer access to the upper atmosphere or space itself. Researchers can also conduct experiments on sounding rockets or satellites. These opportunities are expensive, infrequent and may impose highly limiting operational constraints. Our spaceflight system is intended to provide the scientific research community access to space for affordable and repeatable high-quality microgravity. Our suborbital platform is an end-to-end offering, which includes not only our vehicles, but also the hardware such as middeck lockers that we provide to researchers that request them, along with the processes and facilities needed for a successful campaign. The platform offers a routine, reliable and responsive service allowing for experiments to be repeated rapidly and frequently and with the opportunity to be tended in-flight by one or more researchers. This capability will enable scientific experiments as well as educational and research programs to be carried out by a broader range of individuals, organizations and institutions than ever before. Our commitment to advancing research and science has been present in all of our spaceflights to date. Most recently, in May of 2021, we carried payloads into space for research purposes through NASA's Flight Opportunities Program, and our flight in July of 2021 included research payloads from the University of Florida.
We have also leveraged our knowledge and expertise in manufacturing spaceships to occasionally perform engineering services, such as research, design, development, manufacturing and integration of advanced technology systems.
Factors Affecting Our Performance
28
We believe that our performance and future success depend on a number of factors that present significant opportunities for us but also pose risks and challenges, including those discussed below and in Part 1, Item 1A. of our Annual Report on Form 10-K titled “Risk Factors.”
Impact of COVID-19
The COVID-19 pandemic and the protocols and procedures we implemented in response to the pandemic caused delays to our business and operations, which led to accumulated impacts to both schedule and cost efficiency and some delays in operational and maintenance activities, including delays in our test flight program. While we are no longer experiencing delays from these measures, the longevity and extent of the COVID-19 pandemic remain uncertain, including due to the emergence and impact of the COVID-19 variants. Measures we may need to take in the future and challenges that result from the pandemic could affect our operations necessary to complete the development of our spaceflight systems, our scheduled flight test programs and commencement of our commercial flights. See the section entitled Part II, Item 1A. "Risk Factors" for further discussion of the impacts of the COVID-19 pandemic on our business. We believe our cash and cash equivalents on hand at March 31, 2022, and management's operating plan, will provide sufficient liquidity to fund our operations for at least the next twelve months from the issuance of these financial statements included in this Quarterly Report on Form 10-Q.
Commercial Launch of Our Human Spaceflight Program
We are in the final phases of developing our commercial spaceflight program. Prior to launch of commercial service, we must complete a period of planned maintenance and enhancements to the vehicles, as well as subsequent vehicle flight testing. Commercial service is currently expected to commence in the first quarter of 2023. We continuously monitor our supply chain for potential risk associated with the delivery of materials from our suppliers, which in turn could impact the schedule for completion of the enhancement period and the start of commercial service. We have identified some areas of risk for timely delivery and continue to work on mitigating these identified risks. Any delays in successful completion of our test flight program, whether due to the supply chain, the impact of COVID-19 or otherwise, will impact our ability to generate revenue from human spaceflight.
Customer Demand
While not yet in commercial service for human spaceflight, we have already received significant interest from potential future astronauts. Going forward, we expect the size of our backlog and the number of future astronauts that have flown to space on our spaceflight system to be an important indicator of our future performance. As of April 30, 2022, we had reservations for space flights for approximately 800 future astronauts. In August 2021, following Sir Richard Branson's successful test flight, we reopened ticket sales to a select group and increased the pricing of our consumer offerings to a base price of $450,000 per seat. In February 2022, we opened ticket sales to the general public. As of April 30, 2022, we received more than 150 additional reservations since reopening ticket sales in 2021 and 2022. The customer deposits received represents approximately $200.0 million in expected future revenue upon completion of space flights.
We recently became the first spaceline to receive FAA approval to carry commercial customers to space. This was through an update to our existing commercial spaceflight license which we have held since 2016.
Available Capacity and Annual Flight Rate
We expect to commence commercial operations with a single spaceship, VSS Unity, and a single mothership carrier aircraft, VMS Eve, which together comprise our only spaceflight system. As a result, our annual flight rate will be constrained by the availability and capacity of this spaceflight system. To reduce this constraint, we are currently developing our newest spaceship, VSS Imagine and expect to commence flight test in the second half of 2022. We intend to expand our fleet with our next generation vehicles, our Delta class spaceships and our next generation motherships, which will allow us to increase our annual flight rate. We believe that expanding the fleet will allow us to increase our annual flight rate once commercialization is achieved.
Safety Performance of Our Spaceflight Systems
Our spaceflight systems are highly specialized with sophisticated and complex technology. We have built operational processes to ensure that the design, manufacture, performance and servicing of our spaceflight systems meet rigorous quality
29
standards. However, our spaceflight systems are still subject to operational and process risks, such as manufacturing and design issues, human errors, or cyber-attacks. Any actual or perceived safety issues may result in significant reputational harm to our business and our ability to generate human spaceflight revenue.
Components of Results of Operations
Revenue
To date, we have primarily generated revenue by transporting scientific commercial research and development payloads using our spaceflight systems and by providing engineering services. We also have generated revenues from sponsorship arrangements.
Following the commercial launch of our human spaceflight services, we expect the significant majority of our revenue to be derived from ticket sales to fly to space and related services. We also expect that we will continue to receive a small portion of our revenue by providing services relating to the research, design, development, manufacture and integration of advanced technology systems.
Customer Experience
Customer experience expenses related to spaceflight operations include the consumption of a rocket motor and fuel and other consumables, as well as payroll and benefits for our pilots and ground crew. Customer experience expenses related to the payload cargo services, as well as engineering services, consist of materials and human capital, such as payroll and benefits, to perform these services. Additionally, customer experience expenses include costs associated with maintaining and growing our Future Astronaut community, as well as hospitality, medical, safety, security, training, and facility costs that are for the benefit of our astronauts.
Selling, General and Administrative
Selling, general and administrative expenses consist of human capital related expenses for employees involved in general corporate functions, including executive management and administration, accounting, finance, tax, legal, information technology, marketing and commercial, and human resources; rent relating to facilities, including a portion of the lease with Spaceport America, and equipment; professional fees; and other general corporate costs. Human capital expenses primarily include salaries, cash bonuses, stock-based compensation and benefits. As we continue to grow as a company, we expect that our selling, general and administrative costs will increase on an absolute dollar basis.
Research and Development
Research and development expense represents costs incurred to support activities that advance our human spaceflight system towards commercialization, including basic research, applied research, concept formulation studies, design, development, and related testing activities. Research and development costs consist primarily of the following costs for developing our spaceflight systems:
•flight testing programs, including rocket motors, fuel, and payroll and benefits for pilots and ground crew performing test flights;
•equipment, material, and labor hours (including from third party contractors) for developing the spaceflight system’s structure, spaceflight propulsion system, and flight profiles; and
•rent, maintenance, and other overhead expenses allocated to the research and development departments.
As of March 31, 2022, our current primary research and development objectives focus on the development of our mothership and spaceship vehicles for commercial spaceflights and developing our rocket motor, a hybrid rocket propulsion system that will be used to propel our spaceship vehicles into space. The successful development of mothership, spaceship and rocket motor involves many uncertainties, including:
•our ability to recruit and retain skilled engineering and manufacturing staff;
30
•timing in finalizing spaceflight systems design and specifications;
•successful completion of flight test programs, including flight safety tests;
•our ability to obtain additional applicable approvals, licenses or certifications from regulatory agencies, if required, and maintaining current approvals, licenses or certifications;
•performance of our manufacturing facilities despite risks that disrupt productions, such as natural disasters and hazardous materials;
•performance of a limited number of suppliers for certain raw materials and components;
•performance of our third-party contractors that support our research and development activities including the quality of components and subassemblies;
•our ability to maintain rights from third parties for intellectual properties critical to research and development activities;
•continued access to launch sites and airspace;
•our ability to continue funding and maintain our current research and development activities; and
•the impact of the ongoing global COVID-19 pandemic.
A change in the outcome of any of these variables could delay the development of our motherships, spaceships, or rocket motors, which in turn could impact when we are able to commence our human spaceflights.
As we are currently still in our final development and testing stage of our spaceflight system, we have expensed all research and development costs associated with developing and building our spaceflight system. We expect that our research and development expenses will decrease once technological feasibility is reached for our spaceflight systems as the costs incurred to manufacture additional spaceship vehicles, built by leveraging the invested research and development, will no longer qualify as research and development activities.
Depreciation and Amortization
Depreciation of property, plant, and equipment, net is calculated using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the shorter period of the estimated life or the lease term. Once we have completed our test flight program and commenced commercial operations, we will capitalize the cost to construct any unfinished and additional spaceships and motherships. As these additional spaceships and motherships are placed into service, the related depreciation will be included in the Depreciation and Amortization line item on the condensed consolidated statements of operations and comprehensive loss. We have not capitalized any spaceship development costs to date.
Change in Fair Value of Warrants
Change in fair value of warrants reflects the non-cash change in the fair value of warrants. Certain warrants issued as part of the Company's initial public offering in 2017 and assumed upon the consummation of the Business Combination were recorded at their fair value on the date of the Business Combination and are remeasured as of any warrant exercise date and at the end of each reporting period.
Interest Income
Interest income primarily includes interest earned on our cash and cash equivalents and marketable securities.
Interest Expense
Interest expense consists of amortization of debt issuance costs and contractual interest expense for our 2027 Notes, as well as interest expense related to our finance lease obligations.
31
Other Income
Other income consists of miscellaneous non-operating items, such as gains on marketable securities and handling fees related to customer refunds.
Income Tax Provision
We are subject to income taxes in the United States and the United Kingdom. Our income tax provision consists of an estimate of federal, state, and foreign income taxes based on enacted federal, state, and foreign tax rates, as adjusted for allowable credits, deductions, uncertain tax positions, changes in the valuation of our deferred tax assets and liabilities, and changes in tax laws.
Results of Consolidated Operations
The following tables set forth our results of operations for the periods presented and expresses the relationship of certain line items as a percentage of revenue for those periods. The period-to-period comparisons of financial results is not necessarily indicative of future results.
Three Months Ended March 31, | |||||||||||||||||
2022 | 2021 | ||||||||||||||||
(In thousands) | |||||||||||||||||
Revenue | $ | 319 | $ | — | |||||||||||||
Operating expenses: | |||||||||||||||||
Customer experience | 25 | — | |||||||||||||||
Selling, general and administrative | 37,007 | 43,319 | |||||||||||||||
Research and development | 51,827 | 35,089 | |||||||||||||||
Depreciation and amortization | 2,852 | 2,869 | |||||||||||||||
Total operating expenses | 91,711 | 81,277 | |||||||||||||||
Operating loss | (91,392) | (81,277) | |||||||||||||||
Interest income | 818 | 325 | |||||||||||||||
Interest expense | (2,474) | (7) | |||||||||||||||
Change in fair value of warrants | — | (48,719) | |||||||||||||||
Other income (expense), net | 16 | 27 | |||||||||||||||
Loss before income taxes | (93,032) | (129,651) | |||||||||||||||
Income tax expense | (25) | (43) | |||||||||||||||
Net loss | $ | (93,057) | $ | (129,694) |
For the Three Months Ended March 31, 2022 Compared to the Three Months Ended March 31, 2021
Revenue
Three Months Ended March 31, | $ Change | % Change | |||||||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||||||||
(In thousands, except %) | |||||||||||||||||||||||||||||
Revenue | $ | 319 | $ | — | $ | 319 | 100 | % |
32
We recorded $0.3 million of revenue for the three months ended March 31, 2022. This revenue was attributable to membership fees related to our Future Astronaut community as well as the performance of engineering services. We did not record any revenue for the three months ended March 31, 2021.
Customer Experience
Three Months Ended March 31, | $ Change | % Change | |||||||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||||||||
(In thousands, except %) | |||||||||||||||||||||||||||||
Customer experience | $ | 25 | $ | — | $ | 25 | 100 | % |
Customer experience expenses for the three months ended March 31, 2022 consisted of costs related to the performance of engineering services. We did not record any customer experience expenses in the three months ended March 31, 2021.
Selling, General and Administrative
Three Months Ended March 31, | $ Change | % Change | |||||||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||||||||
(In thousands, except %) | |||||||||||||||||||||||||||||
Selling, general and administrative | $ | 37,007 | $ | 43,319 | $ | (6,312) | (15) | % |
Selling, general and administrative expenses decreased by $6.3 million, or 15%, to $37.0 million for the three months ended March 31, 2022 from $43.3 million for the three months ended March 31, 2021. This decrease was primarily due to a $10.8 million decrease in stock-based compensation. This decrease was partially offset with increases of $2.5 million of consulting, professional and legal fees and $1.6 million in salary, bonus, contract labor, and other benefits.
Research and Development
Three Months Ended March 31, | $ Change | % Change | ||||||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||||||||
(In thousands, except %) | ||||||||||||||||||||||||||
Research and development | $ | 51,827 | $ | 35,089 | $ | 16,738 | 48 | % |
Research and development expenses increased by $16.7 million, or 48%, to $51.8 million for the three months ended March 31, 2022 from $35.1 million for the three months ended March 31, 2021. The increase was primarily due to costs
33
associated with developing our spaceflight system, specifically a $15.5 million increase in contract labor and a $1.2 million increase in facilities costs.
Depreciation and Amortization
Three Months Ended March 31, | $ Change | % Change | ||||||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||||||||
(In thousands, except %) | ||||||||||||||||||||||||||
Depreciation and amortization | $ | 2,852 | $ | 2,869 | (17) | (1) | % |
Depreciation and amortization expenses were $2.9 million for the three months ended March 31, 2022 and 2021.
Change in the Fair Value of Warrants
Three Months Ended March 31, | $ Change | % Change | ||||||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||||||||
(In thousands, except %) | ||||||||||||||||||||||||||
Change in fair value of warrants | $ | — | $ | (48,719) | $ | 48,719 | (100) | % |
Change in fair value of warrants reflects the non-cash change in the fair value of warrants. No warrants were outstanding during the three month period ended March 31, 2022.
Interest Income
Three Months Ended March 31, | $ Change | % Change | ||||||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||||||||
(In thousands, except %) | ||||||||||||||||||||||||||
Interest income | $ | 818 | $ | 325 | $ | 493 | 152 | % |
Interest income increased by $0.5 million, or 152%, to $0.8 million for the three months ended March 31, 2022 from $0.3 million for the three months ended March 31, 2021. The increase was primarily due to interest earned on marketable securities.
Interest Expense
Three Months Ended March 31, | $ Change | % Change | ||||||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||||||||
(In thousands, except %) | ||||||||||||||||||||||||||
Interest expense | (2,474) | (7) | $ | (2,467) | 35,243 | % |
Interest expense increased by $2.5 million, or 35,243%, to expense of $2.5 million for the three months ended March 31, 2022 from expense of less than $0.1 million for the three months ended March 31, 2021. The increase was attributable to interest expense and amortization of debt issuance costs related to our senior convertible notes.
34
Other Income, net
Three Months Ended March 31, | $ Change | % Change | ||||||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||||||||
(In thousands, except %) | ||||||||||||||||||||||||||
Other income, net | $ | 16 | $ | 27 | $ | (11) | (41) | % |
Other income, net for the three months ended March 31, 2022 and 2021 was less than $0.1 million.
Income Tax Expense
Three Months Ended March 31, | $ Change | % Change | ||||||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||||||||
(In thousands, except %) | ||||||||||||||||||||||||||
Income tax expense | $ | (25) | $ | (43) | $ | 18 | (42) | % |
Income tax expense was immaterial for the three months ended March 31, 2022 and 2021. We have accumulated net operating losses at the federal and state level as we have not yet started commercial operations. We maintain a substantially full valuation allowance against our net U.S. federal and state deferred tax assets. The income tax expenses shown above are primarily related to minimum state filing fees in the states where we have operations as well as corporate income taxes for our operations in the United Kingdom, which operates on a cost-plus arrangement.
Liquidity and Capital Resources
As of March 31, 2022, we had cash, cash equivalents and restricted cash of $636.8 million and $580.0 million in marketable securities. Our principal sources of liquidity have come from our sales of our common stock.
In January 2022, we completed an offering of convertible senior notes ("2027 Notes") due on February 1, 2027, unless earlier repurchased, redeemed or converted, and received aggregate proceeds of $425 million, before deducting costs of issuance of $11.2 million. The 2027 Notes are senior, unsecured obligations of the Company, and bear interest at a fixed rate of 2.50% per year. Interest is payable in cash semi-annually in arrears on February 1 and August 1 of each year, beginning on August 1, 2022. The 2027 Notes mature on February 1, 2027 unless earlier repurchased, redeemed or converted. In connection with the 2027 Notes, we entered into capped call transactions with respect to our common stock (the "2027 Capped Calls"). We paid an aggregate amount of $52.3 million for the 2027 Capped Calls. See Note 11 in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional information on the 2027 Capped Calls.
35
Historical Cash Flows
Three Months Ended March 31, | |||||||||||||||||
2022 | 2021 | ||||||||||||||||
(In thousands) | |||||||||||||||||
Net cash provided by (used in) | |||||||||||||||||
Operating activities | (66,051) | (48,769) | |||||||||||||||
Investing activities | (206,671) | (819) | |||||||||||||||
Financing activities | 359,517 | 289 | |||||||||||||||
Net change in cash and cash equivalents and restricted cash | 86,795 | (49,299) |
Operating Activities
Net cash used in operating activities was $66.1 million for the three months ended March 31, 2022, primarily consisting of $93.1 million of net losses, adjusted for non-cash items, which primarily included depreciation and amortization expense of $2.9 million, stock based compensation expense of $10.9 million, amortization of debt issuance costs of $0.4 million, as well as $12.8 million of cash consumed by working capital.
Net cash used in operating activities was $48.8 million for the three months ended March 31, 2021, primarily consisting of $129.7 million of net losses, adjusted for non-cash items, which primarily included depreciation and amortization expense of $2.9 million, stock based compensation expense of $22.1 million, and change in fair value of warrants of $48.7 million, as well as a $7.2 million increase in cash consumed by working capital.
Investing Activities
Net cash used in investing activities was $206.7 million for the three months ended March 31, 2022, primarily consisting of $204.9 million purchases of marketable securities, as well as $1.8 million in capital expenditures.
Net cash used in investing activities was $0.8 million for the three months ended March 31, 2021, primarily consisting of the completion of construction activities at the Gateway to Space facility and less purchases of IT infrastructure and tooling and manufacturing equipment.
Financing Activities
Net cash provided by financing activities was $359.5 million for the three months ended March 31, 2022, consisting primarily of the issuance of the 2027 Notes for net proceeds of $413.8 million, offset by the purchase of the 2027 Capped Calls of $52.3 million and tax withholding for net settled stock-based awards of $1.9 million.
Net cash used in financing activities was $0.3 million for the three months ended March 31, 2021, consisting primarily of net cash proceeds from issuance of common stock, offset by tax withholding for stock options exercised.
Funding Requirements
We expect our expenses to increase substantially in connection with our ongoing activities, particularly as we continue to advance the development of our spaceflight system and the commercialization of our human spaceflight operations. In addition, we expect customer experience expenses to increase significantly as we commence commercial operations and add additional spaceships to our operating fleet.
Specifically, our operating expenses will increase as we:
•scale up our manufacturing processes and capabilities to support expanding our fleet with additional spaceships, carrier aircraft and rocket motors upon commercialization;
•pursue further research and development on our future human spaceflights, including those related to our research and education efforts on point-to-point travel;
36
•hire additional personnel in research and development, manufacturing operations, testing programs, maintenance operations and guest services as we increase the volume of our spaceflights upon commercialization;
•seek regulatory approval for any changes, upgrades or improvements to our spaceflight technologies and operations in the future, especially upon commercialization;
•maintain, expand and protect our intellectual property portfolio; and
•hire additional personnel in management to support the expansion of our operational, financial, information technology, and other areas to support our operations as a public company.
Although we believe that our current capital is adequate to sustain our operations for at least the next twelve months, changing circumstances may cause us to consume capital significantly faster than we currently anticipate, and we may need to spend more money than currently expected because of circumstances beyond our control. Additionally, we are in the final phases of developing our commercial spaceflight program. While we anticipate initial commercial launch with a single spaceship, we currently have an additional spaceship vehicles under construction. We anticipate the costs to manufacture additional vehicles will begin to decrease as we continue to scale up our manufacturing processes and capabilities. Until we achieve technological feasibility with our spaceflight systems, we will not capitalize expenditures incurred to construct any additional components of our spaceflight systems and we will continue to expense these costs as incurred to research and development.
Short-term Liquidity and Capital Resources
For at least the next twelve months, we expect our principal demand for funds will be for our ongoing activities described above. We expect to meet our short-term liquidity requirements primarily through our cash, cash equivalents and marketable securities on hand. We believe we will have sufficient liquidity available to fund our business needs, commitments and contractual obligations in a timely manner for the next twelve months.
Long-term Liquidity and Capital Resources
Beyond the next twelve months, our principal demand for funds will be to sustain our operations, including the construction of additional motherships and spaceship vehicles, construction of our astronaut campus, expansion of the New Mexico Spaceport, and for the payment of the principal amount of our convertible senior notes as it becomes due. We expect to begin generating revenue from our human spaceflight program, which is expected to launch in the fourth quarter of 2022. To the extent this source of capital as well as the sources of capital described above are insufficient to meet our needs, we may also conduct additional public offerings of our securities or refinance debt. We expect these resources will be adequate to fund our ongoing operating activities.
The commercial launch of our human spaceflight program and the anticipated expansion of our fleet have unpredictable costs and are subject to significant risks, uncertainties and contingencies, many of which are beyond our control, that may affect the timing and magnitude of these anticipated expenditures. Some of these risk and uncertainties are described in more detail in our Annual Report on Form 10-K under the heading Item 1A. “Risk Factors—Risks Related to Our Business.”
Contractual Obligations and Commitments
Except as set forth in Note 17, Commitments and Contingencies, of the notes to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q, there have been no material changes outside the ordinary course of business to our contractual obligations and commitments as described in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K.
Critical Accounting Policies and Estimates
37
Our discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of our condensed consolidated financial statements and related disclosures requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures. We believe that the estimates, assumptions and judgments involved in the accounting policies described below have the greatest potential impact on our financial statements and, therefore, we consider these to be our critical accounting policies. Accordingly, we evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions and conditions. Please refer to Note 2 in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for information about these critical accounting policies, as well as a description of our other significant accounting policies.
Recent Accounting Pronouncements
Please refer to Note 3 in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for a description of recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted as of the date of this Quarterly Report on Form 10-Q.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
We have operations within the United States and the United Kingdom and as such we are exposed to market risks in the ordinary course of our business, including the effects of interest rate changes and fluctuations in foreign currency exchange rates. We are also exposed to market risk from changes in our stock prices, which impact the fair value of our 2027 Notes. Information relating to quantitative and qualitative disclosures about these market risks is set forth below.
Interest Rate Risk
We had cash, cash equivalents and marketable securities totaling $1.2 billion as of March 31, 2022, of which $1.1 billion was invested in money market funds, certificate deposits, and corporate debt securities. Our cash and cash equivalents are held for working capital purposes. Our marketable securities are held for capital preservation purposes. We do not enter into investments for trading or speculative purposes.
Our cash equivalents and our investment portfolio are subject to market risk due to changes in interest rates. Fixed rate securities may have their market value adversely affected due to a rise in interest rates. Due in part to these factors, our future investment income may fall short of our expectations due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that decline in market value due to changes in interest rates. However, because we classify our marketable securities as “available for sale,” no gains are recognized due to changes in interest rates. As losses due to changes in interest rates are generally not considered to be credit related changes, no losses in such securities are recognized due to changes in interest rates unless we intend to sell, it is more likely than not that we will be required to sell, we sell prior to maturity or we otherwise determine that all or a portion of the decline in fair value are due to credit related factors.
In January 2022, we issued the 2027 Notes due February 1, 2027 unless earlier repurchased, redeemed or converted with a principal amount of $425.0 million. Concurrently with the issuance of the 2027 Notes, we entered into separate capped call transactions. The 2027 Capped Calls were completed to reduce the potential dilution from the conversion of the 2027 Notes. The 2027 Notes have a fixed annual interest rate of 2.50%. Accordingly, we do not have economic interest rate exposure on the 2027 Notes. However, changes in market interest rates impact the fair value of the 2027 Notes. In addition, the fair value of the 2027 Notes fluctuates when the market price of our common stock fluctuates. The fair value was determined based on the quoted bid price of the 2027 Notes in an over-the-counter market on the last trading day of the reporting period.
As of March 31, 2022, a hypothetical 10% relative change in interest rates would not have had a material impact on the value of our cash equivalents or investment portfolio. Fluctuations in the value of our cash equivalents and investment portfolio caused by a change in interest rates (gains or losses on the carrying value) are recorded in other comprehensive income (loss), and are realized only if we sell the underlying securities prior to maturity.
Foreign Currency Risk
38
The functional currency of our operations in the United Kingdom is the local currency. We translate the financial statements of the operations in the United Kingdom to United States Dollars and as such we are exposed to foreign currency risk. Currently, we do not use foreign currency forward contracts to manage exchange rate risk, as the amount subject to foreign currency risk is not material to our overall operations and results.
Item 4. Controls and Procedures
Limitations on Effectiveness of Controls and Procedures
In designing and evaluating our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2022, our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the three months ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
39
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
We are from time to time subject to various claims, lawsuits and other legal and administrative proceedings arising in the ordinary course of business. Some of these claims, lawsuits and other proceedings may involve highly complex issues that are subject to substantial uncertainties, and could result in damages, fines, penalties, non-monetary sanctions or relief. However, we do not consider any such claims, lawsuits or proceedings that are currently pending, individually or in the aggregate, to be material to our business or likely to result in a material adverse effect on our future operating results, financial condition or cash flows. See Note 17 in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional information.
Item 1A. Risk Factors
For a discussion of our potential risks and uncertainties, see the risk factors previously disclosed in Part I, Item 1A. "Risk Factors" of our Annual Report on Form 10-K, which risk factor section is incorporated herein by reference.
Our business, financial condition and operating results can be affected by a number of factors, whether currently known or unknown, including but not limited to those described as risk factors, any one or more of which could, directly or indirectly, cause our actual operating results and financial condition to vary materially from past, or anticipated future, operating results and financial condition. For a discussion of our potential risks and uncertainties, see the risk factors previously disclosed in Part I, Item 1. “Business,” Part I, Item 1A. “Risk Factors,” and Part I, Item 2. “Management's Discussion and Analysis of Financial Condition and Results of Operations" of our Annual Report on Form 10-K and in Part I, Item 2. “Management's Discussion and Analysis of Financial Condition and Results of Operations" in this Quarterly Report on Form 10-Q. There have been no material changes to the risk factors disclosed our Annual Report on Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The information required has been previously disclosed in our Current Report on Form 8-K filed with the Securities and Exchange Commission on January 13, 2022.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
Item 6. Exhibits
The following documents are filed as part of this report:
(1) Exhibits. The following exhibits are filed, furnished or incorporated by reference as part of this Quarterly Report on Form 10-Q.
40
Incorporated by Reference | ||||||||||||||||||||
Exhibit No. | Exhibit Description | Form | File No. | Exhibit | Filing Date | Filed/Furnished Herewith | ||||||||||||||
2.1(1) | 8-K/A | 001-38202 | 2.1 | 07/11/2019 | ||||||||||||||||
2.1(a)(1) | S-4 | 333-233098 | 2.1(a) | 10/03/2019 | ||||||||||||||||
3.1 | 8-K | 001-38202 | 3.1 | 10/29/2019 | ||||||||||||||||
3.2 | 8-K | 001-38202 | 3.2 | 10/29/2019 | ||||||||||||||||
4.1 | 8-K | 001-38202 | 4.2 | 10/29/2019 | ||||||||||||||||
4.2 | 8-K | 001-38202 | 4.1 | 1/13/2022 | ||||||||||||||||
4.3 | 8-K | 001-38202 | 4.2 | 1/13/2022 | ||||||||||||||||
10.1 | 8-K | 001-38202 | 10.1 | 1/13/2022 | ||||||||||||||||
31.1 | * | |||||||||||||||||||
31.2 | * | |||||||||||||||||||
32.1 | ** | |||||||||||||||||||
32.2 | ** | |||||||||||||||||||
101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | * | ||||||||||||||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | * | ||||||||||||||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | * | ||||||||||||||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | * | ||||||||||||||||||
101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document | * | ||||||||||||||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | * | ||||||||||||||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | * |
41
* Filed herewith.
** Furnished herewith.
(1) Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Virgin Galactic Holdings, Inc. | ||||||||
Date: May 5, 2022 | /s/ Michael Colglazier | |||||||
Name: | Michael Colglazier | |||||||
Title: | Chief Executive Officer (Principal Executive Officer) | |||||||
Date: May 5, 2022 | /s/ Douglas Ahrens | |||||||
Name: | Douglas Ahrens | |||||||
Title: | Chief Financial Officer (Principal Financial and Accounting Officer) |
42